How BIOTRONIK Neuro is using artificial intelligence to support spinal cord stimulation patients
BIOTRONIK Neuro adds AI-guided outreach to Prospera SCS, but broader validation will determine its impact on chronic pain support.
BIOTRONIK Neuro adds AI-guided outreach to Prospera SCS, but broader validation will determine its impact on chronic pain support.
Soin Neuroscience and BIOTRONIK Neuro have announced a research collaboration focused on evaluating novel waveform technology and adaptive spinal cord stimulation programming aimed at enhancing chronic pain treatment outcomes. The partnership integrates proprietary signal tuning algorithms from Soin Neuroscience with the programmable Prospera SCS system developed by BIOTRONIK Neuro, reinforcing a broader industry shift toward